Long-term results of bilateral oophorectomy for the treatment of chronic pelvic pain: relief of pain and special hormone replacement therapy requirements

1996 ◽  
Vol 16 (6) ◽  
pp. 538-543 ◽  
Author(s):  
B. A. Reid ◽  
K. F. Gangar ◽  
Vera Rogers ◽  
Elizabeth Thomas ◽  
R. W. Beard
The Lancet ◽  
2003 ◽  
Vol 361 (9353) ◽  
pp. 254 ◽  
Author(s):  
Norman N Chan ◽  
Peter CY Tong ◽  
CC Chow ◽  
Juliana CN Chan

1991 ◽  
Vol 16 (4) ◽  
pp. 231-245 ◽  
Author(s):  
T. C. Hillard ◽  
S. Whitcroft ◽  
M. C. Ellerington ◽  
M. I. Whitehead

2020 ◽  
Vol 7 ◽  
Author(s):  
Eriston Vieira Gomes

The climacteric is a physiological period of the female reproductive cycle characterized by a decrease in the levels of sex hormones, mainly estrogen. It consists of several phases, with amenorrhea as the initial clinical manifestation followed by long-term changes, such as vaginal atrophy. In this context, hormone replacement therapy (HRT) aims to improve the symptoms of female reproductive senescence, seeking to provide a comfortable physical and psychological condition during this period. However, as with any drug treatment, HRT has its risks and benefits, and it is up to the medical practitioner, in agreement with the patient, looking for the best therapeutic option, minimizing the risks and consequences resulting from this clinical approach.


Sign in / Sign up

Export Citation Format

Share Document